Jukka Kantola is the founder and CEO of World Bioeconomy Forum and also the Chair of the World Bioeconomy Association. He talks with Il Bioeconomista before the next G20 which will be held in Brazil, where the circular bioeconomy will be one of the main topics. “This G20 Summit – he says – marks a pivotal moment”
Interview by Mario Bonaccorso
LanzaTech, the Illonois-headquartered carbon recycling company, has been awarded a contract by Jackson Green, a new energy transition platform, to provide their 4G ethanol technology to India’s largest power generation utility company NTPC Limited. NTPC’s facility in Central India will use LanzaTech’s technology platform and second generation bioreactor to convert CO2 emissions and green H2 into ethanol.
Poste Italiane’s ground and air fleet will run on biofuels supplied by Enilive, Eni’s company dedicated to mobility services and products. This will accelerate Poste Italiane’s progress towards achieving its energy transition and carbon neutrality goals set for 2030.
Neste and Mitsubishi Corporation established a strategic partnership focusing on developing value chains for renewable chemicals and plastics for and with Japanese brands. The partners are targeting brands in industries such as food and beverage, apparel, and consumer electronics. Through the partnership, Neste and MC aim to accelerate their efforts to build defossilized supply chains for brand owners in Japan.
Bologna, Italy, will be the capital of circular bioeconomy from 3 to 4 October. The International Forum on Industrial Biotechnology and Bioeconomy (IFIB) will be held in this beautiful city this year at the Golinelli Foudnation.
Stora Enso signed a new EUR 435 million bilateral loan with the European Investment Bank (EIB) to support the its growth in renewable, fiber-based consumer packaging board.
Avantium N.V., a leading company in renewable and circular polymer materials, started a strategic collaboration with leading textile innovators Auping, Monosuisse and Antex. This partnership – the Dutch company states – aims to develop PEF-based yarns, to be used in mattresses for Auping. “This collaboration demonstrates the broad potential of fibers and yarns made from Avantium’s PEF across different application areas, supporting the introduction of PEF to the everyday life of consumers.”
After successfully passing a selection process led by a panel of experts, Global Bioenergies joins the Groupement des Industries Françaises Aéronautiques et Spatiales (GIFAS), and in particular the StartAir club dedicated to start-ups. The aim of this club is to accelerate collaboration between start-ups and companies in the French aerospace industry.
UPM Biochemicals and Nokian Tyres, a leading developer and manufacturer of premium tires, are set for an industry first with its concept tire partly based on UPM BioMotion™ Renewable Functional Fillers (RFF). The partnership will launch UPM’s CO₂-negative Renewable Functional Fillers (From cradle to gate, considering biogenic carbon from UPM’s feedstock and purchasing 100% green electricity) into a new market segment and highlights the possibilities to use a lighter weight, 100% renewable alternative to traditional CO₂-intensive fillers.
“After several months of tests and trials, our teams have now a good control of our process and its critical steps. I welcome their resilience and determination to meet the challenges related to the unique and innovative nature of our process. Based on these achievements, we are very confident in our ability to ensure the start of continuous production of AFYREN NEOXY in 2024, and to make AFYREN a leading player in industrial green chemistry worldwide”. To say it is Nicolas Sordet, Chief Executive Officer of AFYREN, the greentech company that offers manufacturers bio-based, low-carbon ingredients produced using unique fermentation technology based on a completely circular model. The French company provided an update on recent activity of its AFYREN NEOXY plant during a visit organised for individual and institutional shareholders, and confirmed its target to start continuous production in 2024.
IL BIOECONOMISTA 